Normalised EBITDA

Definition

Normalised EBITDA (often used interchangeably with adjusted EBITDA, though adjusted EBITDA usually means a company's own measure of what it excludes) is a company's earnings before interest, tax, depreciation and amortisation, restated to show the sustainable earning power a buyer would inherit. The reported figure is adjusted to remove one-off items, owner-specific costs and non-market arrangements — an owner's salary above or below the market rate, personal expenses run through the business, exceptional legal costs, or the effect of a related-party contract — and to add back or strip out anything that will not recur under new ownership. Because a business is usually valued as a multiple of normalised EBITDA, these adjustments directly change the price: a defensible add-back can be worth many times its value once the multiple is applied. Buyers scrutinise every adjustment in a quality of earnings review, so a seller needs evidence for each one. Presenting a clean, well-supported normalised EBITDA is one of the most valuable pieces of preparation an owner can do before a sale.

Complementary Terms

Concepts that frequently appear alongside Normalised EBITDA in practice.

Quality of Earnings

A quality of earnings (QoE) review is an analysis of how sustainable and reliable a company's reported profits are, carried out during due diligence. Rather than re-auditing the accounts, it tests whether earnings reflect genuine, repeatable trading: it examines revenue recognition, customer concentration, the split between recurring and one-off income, the working-capital cycle, and every adjustment made to arrive at normalised EBITDA.

Deferred Consideration

A portion of the purchase price in an acquisition that is payable at a future date, either as a fixed amount or contingent on the achievement of specified milestones. Deferred consideration must be recognised at fair value at the acquisition date under IFRS 3 and ASC 805, with subsequent changes in value typically recorded through profit or loss.

Working Capital

The difference between current assets and current liabilities, representing the short-term liquidity available to fund day-to-day operations. Effective working capital management ensures a business can meet its obligations while optimising cash flow for growth investment.

Calibration (Valuation)

The IPEV discipline that gives a Fair Value model its memory. Entry inputs (the most recent funding round price, comparable transactions, noted multiples, identified intangible assets) become reference points; deltas are tracked at every measurement date.

EBITDA Bridge

A reconciliation document that maps founder-reported EBITDA to a Fund's maintainable EBITDA, identifying each adjustment per IPEV Section 3.4 with documented evidence. The bridge typically traces non-recurring spend, discontinued lines, one-time items, founder compensation normalisation, and pro-forma adjustments — each with source documentation (board minutes, contracts, payroll) and the known-and-knowable evidence flag.

Fair Value Defence

A founder-side preparation discipline that builds the evidence base a Fund's Fair Value process needs at every measurement date — before the term sheet conversation begins. Distinct from valuation negotiation: a Fair Value defence isn't about arguing for a higher number, it's about producing the inputs the Fund's quarterly Fair Value model will consume for the duration of the investment.

Called Capital

The cumulative amount of committed capital that a general partner has drawn down from limited partners through capital calls to fund investments, management fees, and fund expenses. Called capital represents the actual cash invested by LPs and is used to calculate performance metrics including DPI and TVPI.

Cost of Capital (WACC)

The weighted average cost of capital, representing the blended rate of return a company must earn on its assets to satisfy both debt holders and equity investors. WACC is used as the discount rate in DCF valuations and as a hurdle rate for investment decisions.

Further Reading

Normalised EBITDA: The Adjustments and a Worked EBITDA Bridge

Every common normalisation adjustment and which way it goes, the FRS 102 lease change, and a worked EBITDA bridge that reconciles.

Read more →

How Much Is My Business Worth? What a Buyer Will Pay

How normalised EBITDA sets the base your multiple is applied to.

Read more →

Contingent Liability

A potential obligation arising from past events whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the entity's control, or a present obligation where payment is not probable or the amount cannot be reliably measured.

Read more →

Related FAQ

What is my business worth to a buyer?

A buyer applies a multiple to your normalised earnings and sets that multiple on the quality of your intangible assets — brand, customers, technology, processes and people — not on last year's profit alone.

Read full answer →

How do I prepare my business for sale?

Get the numbers clean and normalised, tidy contracts and intellectual property, reduce founder dependency, and prepare a vendor due diligence pack and data room — all framed around what a buyer's diligence will test.

Read full answer →

How do I value a business I want to buy?

Apply a multiple to the target's normalised earnings, then test whether the intangible assets behind those earnings — customers, technology, brand, people — justify it and will transfer to you.

Read full answer →

Put this knowledge to work

Use Opagio's free tools to measure and grow the intangible assets that drive your business value.